- Home
- CPAY vs WST Comparison
CPAY vs WST Comparison
Compare CPAY & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- WST
- Stock Information
- Founded
- CPAY 1986
- WST 1923
- Country
- CPAY United States
- WST United States
- Employees
- CPAY N/A
- WST N/A
- Industry
- CPAY EDP Services
- WST Medical/Dental Instruments
- Sector
- CPAY Technology
- WST Health Care
- Exchange
- CPAY Nasdaq
- WST Nasdaq
- Market Cap
- CPAY 24.6B
- WST 15.6B
- IPO Year
- CPAY 2010
- WST N/A
- Fundamental
- Price
- CPAY $324.34
- WST $227.12
- Analyst Decision
- CPAY Buy
- WST Buy
- Analyst Count
- CPAY 14
- WST 7
- Target Price
- CPAY $397.17
- WST $331.67
- AVG Volume (30 Days)
- CPAY 468.3K
- WST 646.1K
- Earning Date
- CPAY 08-06-2025
- WST 07-24-2025
- Dividend Yield
- CPAY N/A
- WST 0.37%
- EPS Growth
- CPAY 6.08
- WST N/A
- EPS
- CPAY 14.26
- WST 6.37
- Revenue
- CPAY $4,045,005,000.00
- WST $2,895,800,000.00
- Revenue This Year
- CPAY $13.37
- WST $3.38
- Revenue Next Year
- CPAY $10.56
- WST $5.85
- P/E Ratio
- CPAY $22.74
- WST $35.63
- Revenue Growth
- CPAY 6.68
- WST N/A
- 52 Week Low
- CPAY $265.06
- WST $187.43
- 52 Week High
- CPAY $400.81
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- CPAY 44.60
- WST 59.84
- Support Level
- CPAY $328.12
- WST $219.60
- Resistance Level
- CPAY $337.15
- WST $233.84
- Average True Range (ATR)
- CPAY 8.00
- WST 5.29
- MACD
- CPAY -0.10
- WST 0.60
- Stochastic Oscillator
- CPAY 36.75
- WST 66.82
About CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.